Back to User profile » Dr Oralee Varnado
Papers published by Dr Oralee Varnado:
Patient Preferences for Episodic Migraine Medications: A Discrete Choice Experiment of Self-Injectable Versus Oral Treatments Targeting Calcitonin Gene-Related Peptide Pathway
Whichello C, Viktrup L, Varnado OJ, Quaife M, Trapali M, Tockhorn-Heidenreich A
Patient Preference and Adherence 2025, 19:839-853
Published Date: 29 March 2025
Treatment Patterns and Healthcare Resource Utilization by Gender and Migraine Frequency in Adult Patients Receiving Galcanezumab Versus Standard of Care Preventive Medications Over 24 months: A United States Retrospective Claims Study
Varnado OJ, Vu M, Buysman EK, Kim G, Allenback G, Hoyt M, Trenz H, Cao F, Viktrup L
Patient Preference and Adherence 2025, 19:543-567
Published Date: 1 March 2025
Comparison of Treatment Patterns in Patients with Migraine Initiating Calcitonin Gene-Related Peptide Monoclonal Antibodies: A Retrospective Real-World US Study
Varnado OJ, Brady BL, Zagar AJ, Robles YP, Hoyt M
Patient Preference and Adherence 2024, 18:69-88
Published Date: 9 January 2024
Treatment Patterns, Healthcare Resource Utilization, and Direct Costs Among Patients Initiating Concomitant Use of a Calcitonin Gene-Related Peptide Monoclonal Antibody (CGRP mAb) and Novel Acute Medication in the United States
Varnado OJ, Gulati T, Wheeler A, Hoyt M
Patient Preference and Adherence 2023, 17:3449-3459
Published Date: 18 December 2023
Treatment Patterns for Calcitonin Gene-Related Peptide Monoclonal Antibodies Including Galcanezumab versus Conventional Preventive Treatments for Migraine: A Retrospective US Claims Study
Varnado OJ, Manjelievskaia J, Ye W, Perry A, Schuh K, Wenzel R
Patient Preference and Adherence 2022, 16:821-839
Published Date: 29 March 2022
Treatment progression in sulfonylurea and dipeptidyl peptidase-4-inhibitor cohorts of type 2 diabetes patients on metformin
Peng X, Jiang D, Liu D, Varnado OJ, Bae JP
Patient Preference and Adherence 2016, 10:1539-1546
Published Date: 10 August 2016